Evaluation of Efficacy and Safety of Susanna Implant in Patients With Refractory Glaucoma.
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01314170|
Recruitment Status : Unknown
Verified May 2011 by Adapt Produtos Oftalmológicos Ltda..
Recruitment status was: Not yet recruiting
First Posted : March 14, 2011
Last Update Posted : May 10, 2011
|Condition or disease||Intervention/treatment||Phase|
|Glaucoma||Device: Susanna Implant||Phase 3|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||76 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Official Title:||Evaluation of Efficacy and Safety of Susanna Implant in Patients With Refractory Glaucoma.|
|Study Start Date :||May 2011|
|Estimated Primary Completion Date :||October 2011|
|Estimated Study Completion Date :||October 2011|
No Intervention: Susanna Implant
Patients with refractory glaucoma neovascular type or that failed in trabeculectomy will undergo surgery to place implants Susana.
Device: Susanna Implant
Other Name: ADA-VSUS-01-10
- Study clinical multicenter, phase III, open-label, prospective character to evaluate the efficacy and safety Susanna implant in patients with refractory glaucoma. [ Time Frame: 180 days ]Evaluate the effectiveness of implant susanna in patients with refractory glaucoma.
- Study clinical multicenter, phase III, open-label, prospective character to evaluate the efficacy and safety Susanna implant in patients with refractory glaucoma. " [ Time Frame: 180 days ]Evaluate the safety of implant susanna in patients with refractory glaucoma. i
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01314170
|Contact: Augusto Paranhos, Investigator||55 11 3747-3312|
|Contact: Fernanda Lima, Coordinator||55 11 email@example.com|
|Hospital Israelita Albert Einstein||Not yet recruiting|
|São Paulo, Brazil, 05651-901|
|Contact: Augusto Paranhos, Investigator 55 11 3747-3312|
|Contact: Fernanda Lima, Coordinator 55 11 2151-0723 firstname.lastname@example.org|
|Principal Investigator: Augusto Paranhos, Investigator|
|Principal Investigator:||Remo Susanna, Investigator||Hospital das Clínicas de São Paulo|
|Principal Investigator:||Renato Lisboa, Investigator||UNIFESP - Universidade Federal de São Paulo|
|Principal Investigator:||Cláudia Galvão, Investigator||Hospital Universitário Prof. Edgar Santos - BA|
|Principal Investigator:||Flávia Villas, Investigator||- Instituto brasileiro de Oftalmologia e prevenção da cegueira- BA|
|Principal Investigator:||Fábio Kanadani, Investigator||Hospital Universitário São José - Belo Horizonte|
|Principal Investigator:||Augusto Paranhos, Investigator||Hospital Israelita Albert Einstein|